TNF and rheumatoid arthritis: Moreover, almost all RA under bDMARDs and tsDMARDs treatment in this study were combined with MTX-based csDMARDs, and thus our results might have been biased toward overestimation of the drug retention rates of TNF-α inhibitors [2, 3].